Mercy Cancer Center at Mercy Medical Center - North Iowa

Mason City, Iowa 50401

0 studies enrolling now · 66 studies all time

What they study most

Anal Cancer, Anorexia, Brain and Central Nervous System Tumors, Breast Adenocarcinoma, Breast Cancer, Cachexia, Cancer Survivor, Carcinoma of Unknown Primary, Chemotherapeutic Agent Toxicity, Chronic Lymphocytic Leukemia, Cognitive/Functional Effects, Colorectal Cancer

Studies at this site

• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer — Completed
• Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma — Running, not enrolling
• S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Running, not enrolling
• Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma — Completed
• Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery — Stopped early
• Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia — Stopped early
• Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer — Completed
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer — Stopped early
• Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia — Stopped early
• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy — Completed
• Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia — Stopped early
• Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer — Completed
• Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer — Completed
• Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer — Completed
• Radiation Therapy in Treating Patients With Stage II Prostate Cancer — Completed
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer — Completed
• High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery — Completed
• Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer — Completed
• Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer — Completed
• Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma — Completed
• Creatine in Treating Patients With Cancer-Associated Weight Loss — Completed
• Home-Based Programs for Improving Sleep in Cancer Survivors — Stopped early
• Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme — Completed
• Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma — Completed
• S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases — Completed
• Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole — Completed
• Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement — Completed
• Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy — Completed
• S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer — Completed
• Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer — Stopped early
• Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer — Completed
• Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer — Completed
• Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery — Completed
• Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma — Completed
• Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery — Completed
• Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma — Completed
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer — Completed
• Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery — Completed
• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary — Completed
• Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer — Completed
• Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma — Completed
• Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer — Completed
• Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer — Completed
• Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer — Stopped early
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer — Completed
• Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer — Completed
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer — Completed
• Citalopram in Treating Postmenopausal Women With Hot Flashes — Completed